Phase 2a, Randomized Trial of Mitiperstat Versus Placebo in Patients with COPD at High Risk of Exacerbation (CRESCENDO)
International Journal of Chronic Obstructive Pulmonary Disease · 2025-09 · Volume 20 · 3305-3315
DOI: 10.2147/copd.s524775 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2025-09. Verfasst von Rod Hughes und 12 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory and Immunology Biometrics and Statistical Innovation, AstraZeneca, Cambridge, UK. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Lung, Peroxidase, Enzyme Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Respiratory and Immunology Biometrics and Statistical Innovation, AstraZeneca, Cambridge, UK.
- Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
- Division of Respiratory Medicine and Gastroenterology, University of Dundee, Dundee, UK.
- Respiratory Pharmacology Group, National Heart & Lung Institute, Imperial College London, London, UK.
- General Practitioners Research Institute, Groningen, the Netherlands.
- Observational and Pragmatic Research Institute, Singapore.
ORCID-Profile: Maria G Belvisi, Janwillem W H Kocks
Zitieren
APA
Hughes, R., Brailsford, W., Ferreira, J., Chalmers, J. D., Belvisi, M. G., Kocks, J. W. H., Masters, P., Thomson, P., Łyżwa, D., Rosengren, S., Cooper, J. D., Russell, R. E. K., & Saralaya, D. (2025). Phase 2a, Randomized Trial of Mitiperstat Versus Placebo in Patients with COPD at High Risk of Exacerbation (CRESCENDO). International Journal of Chronic Obstructive Pulmonary Disease, Volume 20, 3305-3315. https://doi.org/10.2147/copd.s524775
Vancouver
Hughes R, Brailsford W, Ferreira J, Chalmers JD, Belvisi MG, Kocks JWH, et al. Phase 2a, Randomized Trial of Mitiperstat Versus Placebo in Patients with COPD at High Risk of Exacerbation (CRESCENDO). International Journal of Chronic Obstructive Pulmonary Disease. 2025;Volume 20:3305-3315. doi:10.2147/copd.s524775
BibTeX
@article{Hughes2025,
author = {Hughes, Rod and Brailsford, Wayne and Ferreira, João and Chalmers, James D and Belvisi, Maria G and Kocks, Janwillem W H and Masters, Pauline and Thomson, Paul and Łyżwa, Dawid and Rosengren, Sanna and Cooper, Jason David and Russell, Richard E K and Saralaya, Dinesh},
title = {Phase 2a, Randomized Trial of Mitiperstat Versus Placebo in Patients with COPD at High Risk of Exacerbation (CRESCENDO)},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2025},
volume = {Volume 20},
pages = {3305--3315},
doi = {10.2147/copd.s524775}
}
EUVIMED